Gleason Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.6K | Buy |
1,220
+21
| +2% | +$509 | ﹤0.01% | 134 |
|
|
2025
Q1 | $30.4K | Buy |
1,199
+19
| +2% | +$481 | 0.01% | 129 |
|
|
2024
Q4 | $31.3K | Buy |
1,180
+19
| +2% | +$504 | 0.01% | 131 |
|
|
2024
Q3 | $33.6K | Sell |
1,161
-522
| -31% | -$15.1K | 0.01% | 130 |
|
|
2024
Q2 | $47.1K | Buy |
1,683
+140
| +9% | +$3.92K | 0.01% | 125 |
|
|
2024
Q1 | $42.8K | Buy |
1,543
+23
| +2% | +$638 | 0.01% | 120 |
|
|
2023
Q4 | $43.8K | Sell |
1,520
-793
| -34% | -$22.8K | 0.01% | 121 |
|
|
2023
Q3 | $76.7K | Buy |
2,313
+26
| +1% | +$863 | 0.02% | 98 |
|
|
2023
Q2 | $83.9K | Sell |
2,287
-102
| -4% | -$3.74K | 0.02% | 94 |
|
|
2023
Q1 | $97.5K | Buy |
2,389
+1,080
| +83% | +$44.1K | 0.03% | 89 |
|
|
2022
Q4 | $67.1K | Sell |
1,309
-518
| -28% | -$26.5K | 0.02% | 100 |
|
|
2022
Q3 | $80K | Buy |
1,827
+544
| +42% | +$23.8K | 0.03% | 90 |
|
|
2022
Q2 | $67K | Sell |
1,283
-51
| -4% | -$2.66K | 0.02% | 99 |
|
|
2022
Q1 | $69K | Buy |
1,334
+71
| +6% | +$3.67K | 0.02% | 104 |
|
|
2021
Q4 | $75K | Buy |
1,263
+9
| +0.7% | +$534 | 0.02% | 93 |
|
|
2021
Q3 | $54K | Buy |
1,254
+11
| +0.9% | +$474 | 0.02% | 107 |
|
|
2021
Q2 | $49K | Buy |
1,243
+12
| +1% | +$473 | 0.02% | 108 |
|
|
2021
Q1 | $45K | Buy |
1,231
+477
| +63% | +$17.4K | 0.02% | 107 |
|
|
2020
Q4 | $28K | Sell |
754
-1,589
| -68% | -$59K | 0.01% | 115 |
|
|
2020
Q3 | $82K | Buy |
2,343
+23
| +1% | +$805 | 0.05% | 74 |
|
|
2020
Q2 | $72K | Buy |
2,320
+24
| +1% | +$745 | 0.04% | 75 |
|
|
2020
Q1 | $71K | Buy |
2,296
+25
| +1% | +$773 | 0.06% | 69 |
|
|
2019
Q4 | $84K | Buy |
+2,271
| New | +$84K | 0.05% | 77 |
|